Co-Founder & Chairman, Moderna | Founder & Chief Executive Officer, Flagship Pioneering
Talk title: The Power of Innovation to Change the World
President & Chief Executive Officer, CHC: Creating Healthier Communities
Talk title: Sustainable Health Equity Innovation
Thomas G. Bognanno has been the President and CEO of CHC: Creating Healthier Communities since 2006. Prior to that, Tom had a distinguished 20-year career with the American Diabetes Association (ADA), serving at several levels in the organization at the state level in New Mexico, Missouri, and Texas. He was promoted to Special Assistant to the CEO in 1998 before becoming Chief Field Officer in 2003. Prior to ADA, he spent six years with the American Cancer Society. Tom was instrumental in revitalizing the community-level infrastructure of ADA and prioritizing volunteer and staff development. He was also one of the chief architects of the Everyday Choices for a Healthier Life partnership with the ADA, the American Heart Association, and the American Cancer Society. At CHC: Creating Healthier Communities, formerly Community Health Charities, Tom leads the organization in its ever-expanding and evolving role as a catalyst for health, wellbeing, and equity. CHC represents thousands of high-impact nonprofits nationwide, working to address the barriers to good health. CHC connects them with capital from corporate, foundation, and government partners to power transformative change and create resilient communities. In partnership with CHC’s national board of directors, Tom has significantly increased the organization’s focus on the social determinants of health, the underlying factors that affect overall wellbeing. Tom serves on several nonprofit boards including ZERO: The End to Prostate Cancer where he chairs the nationwide Prostate Cancer Patient Advisory Board. He also has been appointed to a national steering committee for Pfizer related to cancer patient participation in clinical trials. Additionally, he serves as Secretary for the Board of Directors for the Institute for Sustainable Development. Residing in northern Virginia, Tom and his wife, Suzan, have been married for more than 35 years and raised three children.
Chairman of the Advisory Board | 17th Surgeon General of the United States | Chief of Health Innovations, Canyon Ranch | Distinguished Professor, University of Arizona
Talk title: Welcome
Born to a poor immigrant family in New York City, Richard Carmona experienced homelessness, hunger, and health disparities during his youth. The experiences greatly sensitized him to the relationships among culture, health, education and economic status and ultimately shaped his future. After dropping out of high school, Dr. Carmona enlisted in the U.S. Army in 1967 where he received a GED. By the time he left active duty, he was a Special Forces, combat-decorated Vietnam veteran. He then pursued a college degree and entered medical school at the University of California – San Francisco where he won the prestigious Gold Cane award as the top graduate. Dr. Carmona became a surgeon with a sub-specialty in trauma, burns and critical care and was recruited to Tucson to establish the first trauma system in southern Arizona which he did successfully. Later, while working full time as a hospital and health system CEO, he earned a master’s degree in public health policy and administration at the University of Arizona. Dr. Carmona has served for over 34 years with the Pima County Sheriff’s Department in Tucson, including as deputy sheriff, detective, SWAT team leader and department surgeon. He is one of the most highly decorated police officers in Arizona, and his numerous awards include the National Top Cop Award, the National SWAT Officer of the Year, and the National Tactical EMS Award. Dr. Carmona is a nationally recognized SWAT expert and has published extensively on SWAT training and tactics, forensics, and tactical emergency medical support. Dr. Carmona has also served as a medical director of police and fire departments and is a fully qualified peace officer with expertise in special operations and emergency preparedness, including weapons of mass destruction. In 2006 Vice Admiral Carmona successfully completed the statutory four-year term as Surgeon General and was named vice chairman of Canyon Ranch, CEO of the health division and president of the Canyon Ranch Institute. Dr. Carmona continues his Canyon Ranch leadership role as the Chief of Health Innovations. He also serves on several public corporate boards and works with private equity and venture capital firms to identify emerging science and technology to translate to market for economic and public benefit.
Co-Founder & Executive Director, Lake Nona Impact Forum Talk title: Welcome & Lake Nona Impact Forum
Gloria serves as Vice President of Strategic Alliances for Tavistock and Executive Director of the Lake Nona Institute. Gloria thrives in cultivating relationships and business development efforts that support the long-term mission of advancing leading-edge community wellbeing. She is also a passionate advocate for mental health, as well as, the environment. Gloria specializes in healthcare and life sciences as a real estate executive for a novel community, Lake Nona, focused on optimizing health, human potential, and overall wellbeing in the built environment. The defining trait of the master-designed Lake Nona community is an unparalleled commitment to inspire healthy living, encourage life-long learning, embrace technology and emphasize sustainability. Gloria plays a dual role in executing that mission. In 2012, she co-founded and launched the Lake Nona Impact Forum, an invitation-only global event for health innovators – an intimate gathering that brings together some of the brightest minds across the health and wellness spectrum. In 2016, Gloria lead a diverse group of innovators to create WHIT, a Wellness Home built on Innovation and Technology. WHIT is a living lab that curates technologies and solutions that aim to define healthy living in a residential environment. As Executive Director of the Lake Nona Institute, she also founded, along with researchers at Johnson & Johnson, the Lake Nona Life Project – an epidemiological research project that studies the health of the residents in the community over the course of multiple years.
Co-Founder, The Chopra Foundation | Chairman, Chopra Global Talk title: The Future of Humanity
DEEPAK CHOPRA™ MD, FACP, founder of The Chopra Foundation, a non-profit entity for research on well-being and humanitarianism, and Chopra Global, a modern-day health company at the intersection of science and spirituality, is a world-renowned pioneer in integrative medicine and personal transformation. Chopra is a Clinical Professor of Family Medicine and Public Health at the University of California, San Diego, and serves as a senior scientist with Gallup Organization. He is the author of over 90 books translated into over forty-three languages, including numerous New York Times bestsellers. His 90th book and national bestseller, Metahuman: Unleashing Your Infinite Potential (Harmony Books), unlocks the secrets to moving beyond our present limitations to access a field of infinite possibilities. For the last thirty years, Chopra has been at the forefront of the meditation revolution and his latest book, Total Meditation (Harmony Books, September 22, 2020) helps to achieve new dimensions of stress-free living and joyful living. TIME magazine has described Dr. Chopra as “one of the top 100 heroes and icons of the century.”
Director, National Institutes of Health Talk title: Arts and Health: Prescriptions for the Future
Dr. Collins is the 16th director of the National Institutes of Health. A physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the Human Genome Project, Dr. Collins served as Director of the National Human Genome Research Institute at the NIH from 1993 to 2008. The Human Genome Project consistently met projected milestones ahead of schedule and under budget. This remarkable international project culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. Dr. Collins’ own research laboratory has discovered a number of important genes, including those responsible for cystic fibrosis, neurofibromatosis, Huntington’s disease and most recently, genes for type 2 diabetes and the gene that causes Hutchinson-Gilford progeria syndrome. Prior to coming to the NIH in 1993, he spent nine years on the faculty of the University of Michigan, where he was a Howard Hughes Medical Institute investigator. He is an elected member of the Institute of Medicine and the National Academy of Sciences. Dr. Collins was awarded the Presidential Medal of Freedom in 2007 and, in 2009, the National Medal of Science, the highest honor bestowed on scientists by the United States government. Dr. Collins received a B.S. in chemistry from the University of Virginia, a Ph.D. in physical chemistry from Yale University, and an MD with honors from the University of North Carolina at Chapel Hill.
Executive Director European Medicines Agency | Chairperson, International Coalition of Medicines Regulatory Authority Talk title: Moving Towards Greater Regulatory Coordination: Why Regulation Matters
Emer Cooke is as of 16 November 2020 the new Executive Director of the European Medicines Agency, based in Amsterdam. She also takes the role of Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) for a term of 2 years. She was the Director responsible for all medical product-related regulatory activities at the World Health Organization in Geneva between November 2016 and November 2020. In this role, Ms. Cooke was responsible for leading WHO’s global work on regulation of health technologies (medicines, vaccines, diagnostics, vector control products and devices), coordinating the regulatory teams (Prequalification, Regulatory Systems Strengthening, and Safety), and working with member states and international partners to assure the quality, safety, and efficacy of appropriate health technologies. Ms. Cooke is a pharmacist with Masters degrees in Science and Business Administration from Trinity College Dublin. She has over 30 years’ experience in international regulatory affairs and spent 14 years (2002 to 2016) in management positions at the European Medicines Agency as Head of Inspections and Head of International Affairs respectively. From September 1998 to July 2002, she worked in the Pharmaceuticals unit of the European Commission.
Principal, Health & Government Solutions, KPMG US Talk title: Sustainable Health Equity Innovation
Todd is a Principal at KPMG in the US with several years’ experience in the payor and provider sectors. Certified in several managed care and clinical applications, his strengths include Health equity strategy development, Patient access, IT Strategy, EHR strategy development, IT/IS program management, Intelligent automation, facilitation and Target operating model development. He has proven interpersonal skills, team leadership experience, and organization skills. His system implementation knowledge, experience in hospital administration, and team leadership skills provide an excellent foundation to deliver quality solutions.
Health Tech Investor, OMERS Ventures Talk title: Societal Resilience: The Pandemic as the Catalyst for Innovation
Christina Farr is a San Francisco-based health-tech investor with a background in journalism. She’s a principal at OMERS Ventures based in the Bay Area. Previously, she was a writer and frequent on-air contributor for CNBC, Fast Company and Reuters News, among other publications. She was raised in London, UK, and received graduate degrees from University College London and Stanford University.
World Renowned Soprano | Advocate for Arts Education, Music Therapy, and Music Neuroscience Research Talk title: Arts and Health: Prescriptions for the Future
Renée Fleming is one of the most highly acclaimed singers of our time, performing on the stages of the world’s greatest opera houses and concert halls. Honored with four Grammy® awards and the US National Medal of Arts, Renée has sung for momentous occasions from the Nobel Peace Prize ceremony to the Diamond Jubilee Concert for Queen Elizabeth II at Buckingham Palace. In 2014, she brought her voice to a vast new audience as the first classical artist ever to sing The Star-Spangled Banner at the Super Bowl. In May, Renée launched Music and Mind LIVE, a weekly web series exploring the intersection of music and arts with human health and the brain. In 19 episodes, the show amassed more than 650,000 views, from 70 countries. Renée was inspired to launch the series by the Sound Health initiative she leads as Artistic Advisor to the John F. Kennedy Center for the Performing Arts, in partnership with the NIH and the NEA. She has given presentations with scientists and practitioners on the connection of arts and health around the world. Earning 17 Grammy nominations, Renée has recorded everything from complete operas and song recitals to jazz and indie rock. Her voice is featured on the soundtracks of Best Picture Oscar winners The Shape of Water and The Lord of the Rings: The Return of the King. Renée’s other awards include the Fulbright Lifetime Achievement Medal, Germany’s Cross of the Order of Merit, and France’s Chevalier de la Légion d’Honneur.
21st Commissioner of the United States Food and Drug Administration Talk title: Moving Towards Greater Regulatory Coordination: Why Regulation Matters
Dr. Margaret (Peggy) Hamburg is an internationally recognized leader in public health and medicine. She is currently serving as VP (interim) for Global biological Programs and Policy, Nuclear Threat Initiative. Dr Hamburg just completed her term as Foreign Secretary of the National Academy of Medicine, where she served as senior advisor on international matters and liaison with other Academies of Medicine around the world. She is also the immediate past Chair/President of the American Association for the Advancement of Science (AAAS), the world’s largest scientific membership organization. Dr. Hamburg is a former Commissioner of the U.S. Food and Drug Administration (FDA), where she was known for advancing regulatory science, modernizing regulatory pathways, and globalization of the agency. Other positions have included: Assistant Secretary for Planning and Evaluation, HHS; VP and Chief Scientist Nuclear Threat Initiative: NYC Heath Commissioner; Assistant Director, National Institute of Allergy and Infectious Diseases, NIH. She currently sits on a number of Boards, including the Lasker Foundation, Commonwealth Fund, the Simons Foundation, the Council on Foreign Relations, the Global Alliance for Vaccines (GAVI) and Alnylam Pharmaceuticals among others. Dr. Hamburg is a graduate of Harvard College and Harvard Medical School. She is widely published and has received numerous awards and honorary degrees.
Principal & Chief Economist, KPMG LLP US Talk title: Sustainable Health Equity Innovation
As Chief Economist for KPMG U.S., Constance Hunter is responsible for macroeconomic analysis and forecasting at the firm. Constance’s expertise allows her to provide insightful perspective on the evolving economic landscape, the impact it has on the firm and its clients. She speaks frequently on wide-ranging macroeconomic topics to global audiences and KPMG’s C-Suite clients. She appears regularly on broadcast media such as Bloomberg TV, Yahoo Finance, CNBC, and Fox Business, and is quoted in the Wall Street Journal, New York Times, and The Washington Post. She holds a BA in Economics and Sociology from New York University and an MA in International Economics from Columbia University School of International and Public Affairs (SIPA). Constance is a passionate equestrian and is on the board of GallopNYC a not-for-profit organization whose therapeutic horsemanship program changes the lives of disabled New Yorkers.
Corporate Vice President, Microsoft Research & Incubations Talk title: The Future of Humanity
Peter Lee is a Corporate VP leading Microsoft’s Research & Incubation division. Lee has extensive experience managing fundamental research to commercial impact. He was previously an Office Director at DARPA and head of the CS Dept at CMU. Lee served on Obama’s Commission on Enhancing National Cybersecurity, is a recently elected Member of the NAM. PhD from U of Michigan.
Founding Executive Director, Centre of Regulatory Excellence, Duke-National University of Singapore Medical School | Inaugural Chairman of the Consortium for Clinical Research & Innovation Singapore | Senior Advisor, Singapore Ministry of Health Talk title: Moving Towards Greater Regulatory Coordination: Why Regulation Matters
Professor John CW Lim is founding Executive Director of the Centre of Regulatory Excellence (CoRE) at the Duke-National University of Singapore Medical School (Duke-NUS), inaugural Chairman of the Consortium for Clinical Research & Innovation Singapore, Senior Advisor at Singapore’s Ministry of Health (MOH), and Policy Core Lead at the SingHealth Duke-NUS Global Health Institute. He is Professor of Practice at Duke-NUS and the NUS Saw Swee Hock School of Public Health. Formerly Chief Executive Officer of Singapore’s Health Sciences Authority and Deputy Director of Medical Services in MOH, Professor Lim has also held other senior positions in Singapore’s Health and Education ministries. His current roles promote capacity building and scientific excellence for health products regulation and health policies in Southeast Asia and the Asia-Pacific. Professor Lim is a member of the Singapore Food Agency Board, APEC Life Sciences Innovation Forum’s Executive Board, Davos Alzheimer’s Collaborative Leadership Group, US Pharmacopoeia Council of the Convention, and Centre for Innovation in Regulatory Science’s Scientific Advisory Council. In 2018, Professor Lim received the Drug Information Association’s Global Connector Inspire Award for leadership in promoting global collaboration to advance healthcare products to patients, and the Regulatory Affairs Professional Society’s highest Founder’s Award recognizing substantial sustained impact in shaping regulatory practice and policy over his career.
Chief Executive Officer, The Chopra Foundation Talk title: The Future of Humanity
Poonacha Machaiah is a global leader among a new breed of social entrepreneurs, having chosen to apply his corporate expertise from 25 years as a business executive in multiple Fortune 100 companies and entrepreneurial initiatives to addressing societal and wellbeing challenges. Poonacha is the CEO of The Chopra Foundation, a 501 (c) (3) organization dedicated to improving health and well-being, cultivating spiritual knowledge, expanding consciousness, and promoting world peace. He is the co-founder of the Never Alone Movement for Suicide Prevention and Mental Health along with both world-renowned mind body medicine pioneer and New York Times best-selling author Deepak Chopra, M.D, actress and humanitarian Gabriella Wright. Poonacha has launched the Warrior Monk brand targeted at creating a positive societal shift through the compassionate transformation of humankind. Poonacha is the founder of Wellbeing Tech, a leading technology innovation company that has deployed transformative wellbeing solutions such as the hyper local neighborhood app i.e. GABL and Remote Assistance Management platform for providing assisted reality with Glass Enterprise edition. He has co-founded startups such as Jiyo and Qyuki. He has also held senior management positions at Nortel, Iridium, Motorola and Sasken. He holds an MBA from the College of William and Mary, and a Bachelor of Science in Computer Science and Engineering from the B.M.S. College of Engineering.
Chairman of the Board & Chief Executive Officer, Bank of America Talk title: How COVID-19 has Reshaped The Workplace Mental Health Landscape
Brian Moynihan leads a team of more than 200,000 employees dedicated to making financial lives better for people, companies of every size, and institutional investors across the United States and around the world. Bank of America has been recognized as a leader in financial services, including on Fortune magazine’s list of The Best Big Companies to Work For, named Global Finance’s Best Bank in the United States and North America in 2020, and placed on Forbes’ World’s Best Employers List in 2019. The company is the top global bank on Fortune’s Change the World list. It was also the 2019 Catalyst Award winner for supporting the continued development, empowerment, and advancement of women in the company and around the world, and is recognized annually as a top employer by Working Mother, LATINA Style, Black Enterprise, Military Times, and U.S Veterans Magazine. Bank of America is included in the Forbes Corporate Responders List of 25 companies leading through the health crisis caused by the coronavirus. Moynihan participates in several organizations that focus on economic and market trends, including the World Economic Forum International Business Council (chair), the Financial Services Forum, the Bank Policy Institute, the Business Roundtable, the Clearing House, the American Heart Association CEO Roundtable (co-chair), the Business Council and the Federal Advisory Council of the Federal Reserve Board. Moynihan leads the company’s Global Diversity and Inclusion Council and is a member of the museum council for the Smithsonian’s National Museum of African American History and Culture. Moynihan is also a member of the Brown University Corporation’s Board of Fellows, the Catalyst Board of Directors, the Council on Competitiveness Board of Directors, and the Appeal of Conscience Board of Trustees. Moynihan works with public officials, businesses, and civic leaders at the local level through his participation on the Charlotte Executive Leadership Council (chair), the Massachusetts Competitive Partnership and the Partnership for Rhode Island.
Chief Executive Officer, Fortune Media (USA) Corporation Talk title: The Big Picture, How has the World Changed? | 5G and a more Sustainable, Inclusive Future
Alan Murray is CEO of Fortune Media. He oversees the business and editorial operations of the independent media company and is known for expanding its digital and conference franchises. Murray also writes a closely-read daily newsletter, the Fortune CEO Daily. Prior to joining Fortune in 2015, Murray led the rapid expansion of the Pew Research Center’s digital footprint as president of that organization. Before that, Murray was at the Wall Street Journal for many years, serving as Deputy Managing Editor, Executive Editor Online, Washington Bureau Chief, and author of the Political Capital and Business columns. He served for several years as Washington bureau chief for CNBC, and cohost of the nightly show Capital Report. He is the author of multiple books, including the classic Showdown at Gucci Gulch: Lawmakers, Lobbyists, and the Unlikely Triumph of Tax Reform
President & Dean, Morehouse School of Medicine Talk title: Sustainable Health Equity Innovation
Valerie Montgomery Rice, MD, FACOG, provides a valuable combination of experience at the highest levels of patient care and medical research, as well as organizational management and public health policy. Marrying her transformational leadership acumen and strategic thinking to tackle challenging management issues, she has a track record of redesigning complex organizations’ infrastructures to reflect the needs of evolving strategic environments and position the organization for success through sustainability tactics. The sixth president of Morehouse School of Medicine (MSM) and the first woman to lead the free-standing medical institution, Montgomery Rice serves as both the president and dean. A renowned infertility specialist and researcher, she most recently served as dean and executive vice president of MSM, where she has served since 2011. Prior to joining MSM, Montgomery Rice held faculty positions and leadership roles at various health centers, including academic health centers. Most notably, she was the founding director of the Center for Women’s Health Research at Meharry Medical College, one of the nation’s first research centers devoted to studying diseases that disproportionately impact women of color. Dedicated to the creation and advancement of health equity, Montgomery Rice lends her vast experience and talents to programs that enhance pipeline opportunities for academically diverse learners, diversifies the physician and scientific workforce, and fosters equity in health care access and health outcomes. To this end, she holds memberships in various organizations and participates on a number of boards, such as the following: member, National Academy of Medicine, the Association of American Medical Colleges Council of Deans, and the Horatio Alger Association and board of directors for The Metro Atlanta Chamber, Kaiser Permanente School of Medicine, The Nemours Foundation, UnitedHealth Group, Westside Future Fund, Josiah Macy Jr. Foundation, Headspace, Wellpath, and CARE. Montgomery Rice has received numerous accolades and honors. She was named to the Horatio Alger Association of Distinguished Americans and received the 2017 Horatio Alger Award. For three consecutive years (2016-2018) Georgia Trend Magazine selected Montgomery Rice as one of the 100 Most Influential Georgians. Other honors include the following: The Dean Griffin Community Service Award from the Georgia Institute of Technology, Girls Inc. 2019 Smart Award, The National Medical Association OB/GYN 2019 Legend of the Section Award, The Turknett Leadership Character Award (2018), Visions of Excellence Award, Atlanta Business League (2018), Links Incorporated Co-Founders Award (2018), Trumpet Vanguard Award (2015), The Dorothy I. Height Crystal Stair Award (2014), National Coalition of 100 Black Women – Women of Impact (2014), YWCA – Women of Achievement of Atlanta-(2014) and Nashville(2007), American Medical Women’s Association Elizabeth Blackwell Medal (2011) and Working Mother Media Multicultural Women’s Legacy Award (2011). A Georgia native, Montgomery Rice holds a bachelor’s degree in chemistry from the Georgia Institute of Technology, a medical degree from Harvard Medical School, an honorary degree from the University of Massachusetts Medical School and a Doctor of Humane Letters honorary degree from Rush University. All reflect her lifetime commitment to education, service, and the advancement of health equity. She completed her residency in obstetrics and gynecology at Emory University School of Medicine and her fellowship in reproductive endocrinology and infertility at Hutzel Hospital.
National Sector Leader, Healthcare & Life Sciences, KPMG in the US Talk title: Sustainable Health Equity Innovation
Ash Shehata is a Principal and National Healthcare and Life Sciences Leader, and a member of the Global Healthcare Center of Excellence at KPMG. Ash works with healthcare providers, global pharmaceutical, biotech and medical device firms, and leading health insurance organizations in innovative, large-scale transformation initiatives. With more than 35 years of experience, he is a sought-after commentator at various industry events, with the media and industry analysts, and has published several whitepapers. Ash brings a diverse industry background having worked at Cisco Systems, Accenture, Anthem and the University of Cincinnati Medical Center.
Founder & Chairman, ONE MIND Talk title: How COVID-19 has Reshaped The Workplace Mental Health Landscape
Garen is Founder and Chairman of ONE MIND (“OM”) a 501.c.3 non-profit: (1) pursuing discoveries in brain health research fostering open science principles; (2) advancing better diagnostics, treatments, early intervention; and (3) eliminating the stigma for all brain illnesses. OM leverages large-scale public/private partnerships as well as individual scientists to achieve these goals. One Mind at Work, a global coalition of 90 employers and partners, now covers more than 25 million employees and their dependents. Over 26 years, OM and the Staglin Music Festival for Brain Health have raised $480M for brain health. Garen is the Founder and Co-Chairman of the Healthy Brains Global Initiative (“HBGI”). With more than 50 volunteer global leaders, a 14-person Board, and a full-time management team, HBGI is assembling new financial sources to complete a $10 billion fund to address the projected $6 Trillion global burden of mental illness. HBGI is working in collaboration with the World Bank, WHO, UNICEF, the Wellcome Trust, and other global leaders and will formally launch at WEF 2021. Garen has a 40-year career as a successful entrepreneur and private equity investor. He is on the Board of SVB, Chairman of ExL Services and Profit Velocity Solutions, is a Senior Advisor to FTV Capital, and recently Co-Chaired the $5.4.8B UCLA Centennial Campaign. He and his family founded Staglin Family Vineyard in 1985 in Napa. The Staglin’s’ motto is “Great Wine for Great Causes.” They have generated over $1.2B through causes they have led, their charity, and wine donations.
Chairman & Chief Executive Officer, Verizon Talk title: 5G and a more Sustainable, Inclusive Future
Hans Vestberg is chairman and chief executive officer of Verizon Communications, a leading provider of wireless, fiber-optic and global Internet networks and services. Prior to assuming the role of CEO in August 2018 and the role of Chairman in March 2019, Mr. Vestberg served as Verizon’s chief technology officer and president of Global Networks from 2017, with responsibility for further developing the architecture for Verizon’s fiber-centric networks. At Verizon, he has focused on transforming the businesses 2.0 customer-centric strategy, leading the company to be first in the world to deploy 5G home and mobile technology, delivering seamless experiences for customers over network assets consisting of the country’s leading 4G LTE network, the nation’s biggest residential fiber network, a global internet backbone and undersea cable network carrying much of the world’s internet traffic, and fiber assets in 45 of the top 50 markets in the U.S. Before joining Verizon in April 2017, Vestberg served for six years as president and CEO of Ericsson, a multinational networking and telecommunications equipment and services company headquartered in Sweden that provides 35 percent of the world’s 2G, 3G, and 4G mobile network infrastructures. For more than a decade after joining Ericsson in 1991, he gained broad international experience with leadership positions on four continents. He was instrumental in developing Ericsson’s industry-leading services organization, which grew three-fold during his five years of management. In 2007 he became Ericsson’s chief financial officer, and he was named CEO in 2009. As CEO, he led more than 115,000 employees as the company transformed from a focus on hardware to software and services.
Co-Chair of the Advisory Board | Dean of the Faculty, Harvard T.H. Chan School of Public Health | Angelopoulos Professor in Public Health and International Development, Harvard T.H. Chan School of Public Health and Harvard Kennedy School Talk title: Welcome & Lake Nona Impact Forum
Michelle A. Williams, SM ’88, ScD ’91, is Dean of the Faculty, Harvard T.H. Chan School of Public Health, and Angelopoulos Professor in Public Health and International Development, a joint faculty appointment at the Harvard Chan School and Harvard Kennedy School. She is an internationally renowned epidemiologist and public health scientist, an award-winning educator, and a widely recognized academic leader. Prior to becoming Dean, she was Professor and Chair of the Department of Epidemiology at the Harvard Chan School and Program Leader of the Population Health and Health Disparities Research Programs at Harvard’s Clinical and Translational Sciences Center. Dean Williams previously had a distinguished career at the University of Washington School of Public Health. Her scientific work places special emphasis in the areas of reproductive, perinatal, pediatric, and molecular epidemiology. Dean Williams has published more than 500 scientific articles and was elected to the National Academy of Medicine in 2016. In 2020, she was awarded the Ellis Island Medal of Honor and recognized by PR Week as one of the top 50 health influencers of the year. The Dean has an undergraduate degree in biology and genetics from Princeton University, a master’s in civil engineering from Tufts University, and master’s and doctoral degrees in epidemiology from the Harvard Chan School.
Board of Directors, Foundation for the National Institutes of Health Talk title: Moving Towards Greater Regulatory Coordination: Why Regulation Matters
Elias Zerhouni, MD, Professor Emeritus Radiology and Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA. Dr. Zerhouni was most recently the President, Global Research & Development, and a member of the Executive Committee for Sanofi from January 2011 to July 2018. Dr. Zerhouni’s academic career was spent at the Johns Hopkins University and Hospital where he was professor of Radiology and Biomedical engineering and senior adviser for Johns Hopkins Medicine. He served as Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences, Vice Dean for Research and Executive Vice Dean of the School of Medicine from 1996 to 2002 before his appointment as Director of the National Institutes of Health from 2002 to 2008. In that position he oversaw the NIH’s 27 Institutes and Centers with more than 18,000 employees and a budget of $29.5 billion (2008). In November 2009, President Obama appointed Dr. Zerhouni as one of the first presidential U.S. science envoys. Dr. Zerhouni also served as senior fellow to the Bill and Melinda Gates foundation from 2009 to 2010 and senior advisor to the CEO of Sanofi. Dr. Zerhouni has founded or co-founded five start-up companies, authored more than 200 publications and holds several patents. He has assumed positions on several Boards, including most recently, the board of the Lasker Foundation, Research!America and the NIH Foundation. He is also a member of the U.S. National Academy of Medicine and the U.S. National Academy of Engineering. He received the prestigious Legion of Honor medal from the French National Order in 2008, and was elected in 2010 as a member of the French Academy of Medicine and appointed as Chair of Innovation at the College de France in 2011